BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-4

  1. 4,402 Posts.
    lightbulb Created with Sketch. 1394
    Reality is that btx1503 has already surpassed products such as epiduo and aczone with $494 mill and $456 mill in revenue respectively after 4 weeks of treatment..

    Market cap currently is ridiculous.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.